Close
Close

Center Trials & Treatment - Glioma of Brain

Partner

Not provided

Rare Disease

Glioma of Brain

Sponsor

Center Trials & Treatment

Access Program Information

This is an expanded access program (EAP) for patient with Melanoma and Glioblastoma who have progressed after prior Protocol therapy including Bevacizumab, Temozolomide ( TMZ ), Ipilimumab, BRAF and MEK inhibitors. The patients whose tumors are EGFR, MET or ALK positive should first receive an EFGR or ALK inhibitor, respectively, prior to treatment with pembrolizumab.

Contact

Contact: Daniel M Cherrett (508 786 670)

Locations
  • Albania
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Romania
  • Russian Federation
  • Serbia
  • Switzerland

Free Newsletter